Companies I

wsjboy

BKD, heal,brookdale senior living,long-trm car faclts  BKD   yahoo  finviz  google  fool  
alpha 29.10,beta 2.99,a_vol 1081, debt 2.53,insi 2.3 2.79,inst 97.8 -0.22,
=================
Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates in six segments: Retirement Centers, Assisted Living, Continuing Care Retirement Communities (CCRCs)–Rental, CCRCs-Entry Fee, Innovative Senior Care, and Management Services. The Retirement Centers segment owns or leases communities comprising independent living and assisted living units in a single community that are primarily designed for middle to upper income senior citizens. The Assisted Living segment owns or leases communities consisting of freestanding, multi-story communities, and freestanding single story communities, which offer housing and 24-hour assistance to mid-acuity frail and elderly residents. This segment also operates memory care communities for residents with Alzheimer's disease and other dementias. The CCRCs-Rental segment owns or leases communities that offer various living arrangements and services to accommodate physical ability and health. The CCRCs-Entry Fee segment allows residents in the independent living apartment units to pay a one-time upfront entrance fee to use certain amenities and services. The Innovative Senior Care segment provides outpatient therapy, home health, and hospice services to residents of its communities and other senior living communities. The Management Services segment operates third party communities under the management agreements. As of December 31, 2012, it operated 76 retirement center communities with 14,528 units; 433 assisted living communities with 21,594 units; 27 rental CCRC communities with 6,748 units; 14 entry fee CCRC communities with 5,866 units; and 97 communities with 17,998 units for third parties. Brookdale Senior Living Inc. is based in Brentwood, Tennessee.
=================
=================

wsjboy

occu

wsjboy

LLTC, tech,linear technology,semicndctr-spclzd, in sp500_set   LLTC   yahoo  finviz  google  fool  
pe 22.89,peg 2.18,alpha 18.50,beta 1.04,a_vol 1832, div 2.66 130814,insi 0.8 -4.8,inst 94.5 0.92,
=================
Linear Technology Corporation, together with its subsidiaries, designs, manufactures, and markets various analog integrated circuits (ICs) worldwide. The company produces power management, data conversion, signal conditioning, µModule subsystems, and wireless sensor network products, as well as radio frequency and interface ICs. Its products comprise amplifiers, high speed amplifiers, voltage regulators, voltage references, interface circuits, data converters, battery stack monitors, silicon oscillators and timer blox, phase locked loop synthesizers, smartmesh wireless sensor network systems, isolated µmodule transceivers, radio frequency circuits, power over Ethernet controllers, µModule power products, and signal chain µModule products, as well as other liner circuits, such as buffers, battery monitors, motor controllers, hot swap circuits, comparators, sample-and-hold devices, timers, oscillators, drivers, and filters. The company’s products have applications in factory automation; process control; industrial and laboratory instrumentation; security monitoring devices; complex medical devices; telecommunications; networking products, such as power over Ethernet switches; automotive electronics; tablet, notebook, and desktop computers; computer peripherals; video/multimedia; military, space, and other harsh environment systems; and high-end consumer products. Linear Technology Corporation sells its products primarily through direct sales staff and electronics distributors. The company was founded in 1981 and is headquartered in Milpitas, California.
=================
凌力尔特公司，连同其附属公司，设计，制造和市场的全球各种模拟集成电路（ICs）。本公司生产的电源管理，数据转换，信号调理，ÂμModule子系统，以及无线传感器网络产品，以及无线电频率和接口IC。其产品包括放大器，高速放大器，稳压器，电压基准，接口电路，数据转换器，电池堆栈显示器，硅振荡器和定时器blox公司，锁相环合成器，smartmesh无线传感器网络系统，隔离Âμmodule收发器，射频电路，权以太网控制器，电源产品ÂμModule，和信号链ÂμModule产品，以及其他班轮电路，如缓冲区，电池监控器，电机控制器，热插拔电路，比较器，采样与保持装置，定时器，振荡器，驱动和过滤器。该companyÂ的产品具有应用在工厂自动化，过程控制，工业和实验室仪器，安全监控设备，复杂的医疗设备，电信，网络产品，如电源在以太网交换机，汽车电子，平板电脑，笔记本电脑，和台式电脑，计算机外围设备，视频/多媒体，军事，航天和其他恶劣的环境系统;和高端消费类产品。凌力尔特公司（Linear Technology Corporation）出售其产品主要通过直销人员和电子分销商。该公司成立于1981年，总部设在加利福尼亚州米尔皮塔斯。
=================

wsjboy

NVO, heal,novo nordisk a/s,ctry denmark,drug manfctrrs-othr, in vil6_set   NVO   yahoo  finviz  google  fool  
pe 23.6,peg 1.63,alpha 12.20,beta 0.62,a_vol 306, div 1.29 130321,insi 0.0 0.0,inst 8.8 -0.58,
=================
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
=================
=================

wsjboy

IMGN, heal,immunogen,biotchnlgy  IMGN   yahoo  finviz  google  fool  
alpha 14.80,beta 1.63,a_vol 735, insi 0.2 -37.16,inst 84.6 -0.04,
=================
ImmunoGen, Inc. engages in the development of antibody-based anticancer therapeutics. The company develops its products using its targeted antibody payload (TAP) technology. Its product candidates include Trastuzumab emtansine, a Phase III clinical trial product for HER2+ metastatic breast cancer; lorvotuzumab mertansine, which is in Phase II clinical trial for the treatment of diagnosed metastatic small-cell lung cancer, as well as in a Phase I clinical trial for the treatment of multiple myeloma; IMGN853, a Phase I clinical trial product that targets over-expressed folate receptor 1 in ovarian cancer and other types of solid tumors, including non-small cell lung cancer; and IMGN529, a product in Phase I clinical trial for treatment of non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia. The companyÂ’s compounds in earlier-stage of development comprise SAR3419, a Phase II clinical trial product to treat CD19-expressing B-cell malignancies, such as NHL and B-cell acute lymphoblastic leukemia; BT-062, a Phase I product, which targets CD138 antigen found on multiple myeloma and various solid tumors; SAR650984, a Phase I clinical trial product for CD38-targeting hematological malignancies; SAR566658, a Phase I clinical trial product for DS6-expressing solid tumors; BAY 94-9343, a Phase I clinical trial product for mesothelin-expressing solid tumors; and Amgen 1 and Amgen 2, which are phase I clinical trial compounds. It has collaborations with Amgen Inc.; Bayer HealthCare; Biotest AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; Genentech, Inc; Sanofi; and Hoffman-La Roche Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
=================
=================

wsjboy

AMGN, heal,amgen,biotchnlgy, in vil6_set sp500_set   AMGN   yahoo  finviz  google  fool  
pe 17.77,peg 2.02,alpha 26.90,beta 0.51,a_vol 3376, div 1.78 130814,debt 1.16,insi 0.1 9.62,inst 82.1 -0.6,
=================
Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. Its principal products include Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body fight infections; Enbrel, an inhibitor of tumor necrosis factor that plays a role in the bodyÂ’s response to inflammatory diseases; Aranesp and EPOGEN erythropoiesis-stimulating agents that stimulate the production of red blood cells; and XGEVA/Prolia (denosumab) to treat men with castration-resistant prostate cancer at high risk of developing bone metastases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides product candidates in mid- to late-stage development in various therapeutic areas comprising oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine, which includes neuroscience. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc; Takeda Pharmaceutical Company Limited; and UCB, as well as a strategic alliance with Astellas Pharma Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
=================
=================

wsjboy

REGN, heal,regeneron pharmaceuticals,biotchnlgy, in sp500_set   REGN   yahoo  finviz  google  fool  
pe 31.22,peg 1.18,alpha 56.60,beta 0.97,a_vol 791, insi 1.6 -12.83,inst 78.5 1.59,
=================
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. The company offers EYLEA injection for the treatment of neovascular age-related macular degeneration and macular edema; ZALTRAP, an injection for intravenous infusion for the treatment of patients with metastatic colorectal cancer; and ARCALYST, an injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its product candidates in clinical development stage consist of EYLEA for the treatment of ophthalmologic diseases; and ZALTRAP for oncology. The companyÂ’s earlier stage clinical programs include various human monoclonal antibodies, such as REGN88 for rheumatoid arthritis; REGN727 for low-density lipoprotein cholesterol reduction; REGN668 for atopic dermatitis and allergic asthma; REGN421, REGN910, and REGN1400 for oncology; REGN475 for the treatment of pain; REGN846 for atopic dermatitis; and REGN1500, REGN1033, and REGN1154. It also conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company distributes its products through third party service providers. It has strategic collaboration with Sanofi to discover, develop, and commercialize human monoclonal antibodies; and license and collaboration agreement with Bayer HealthCare for the development and commercialization of EYLEA outside the United States. The company was founded in 1988 and is headquartered in Tarrytown, New York.
=================
Regeneron公司制药公司，一家生物制药公司，发现，发明，开发，制造，和销售药品，用于治疗严重的医疗条件，在美国和国际。该公司提供EYLEA注射液用于治疗新生血管性年龄相关性黄斑变性和黄斑水肿; ZALTRAP，静脉滴注注射用于治疗转移性结直肠癌患者和ARCALYST，注射皮下使用，用于治疗cryopyrin相关周期性综合征，包括家族性寒冷自身炎症综合征和穆克勒井的综合征在成人和儿童。其产品处于临床开发阶段的候选人包括EYLEA用于治疗眼科疾病;和ZALTRAP肿瘤。的companyâ的早期阶段的临床方案，包括各种人类单克隆抗体，如REGN88类风湿关节炎; REGN727低密度脂蛋白胆固醇降低; REGN668为特应性皮炎和过敏性哮喘; REGN421，REGN910，和肿瘤REGN1400; REGN475治疗疼痛; REGN846特应性皮炎和REGN1500，REGN1033，REGN1154。它还开展在肿瘤血管生成，眼科，代谢及相关疾病，肌肉疾病和失调，炎症和免疫疾病，骨和软骨，疼痛，心血管疾病和传染性疾病领域的临床前研究项目。通过第三方服务供应商，该公司销售其产品。它具有与赛诺菲的战略合作，探索，开发和商业化的人类单克隆抗体和许可合作协议，拜耳医药保健EYLEA在美国以外的开发和商品化。该公司成立于1988年，总部设在纽约的塔利
=================

wsjboy

MYGN, svcs,myriad genetics,reserch servcs  MYGN   yahoo  finviz  google  fool  
pe 18.76,peg 1.27,alpha 17.79,beta 0.39,a_vol 2126, er 130813*,insi 0.2 -2.43,inst 96.6 -0.04,
=================
Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. Its molecular diagnostic tests are designed to analyze genes, their mutations, expression levels, and proteins to assess an individualÂ’s risk for developing disease later in life; determine a patientÂ’s likelihood of responding to a particular drug; assess a patientÂ’s risk of disease progression and disease recurrence; and measure a patientÂ’s exposure to drug therapy to ensure optimal dosing and reduced drug toxicity. The company offers various molecular diagnostic tests that include BRACAnalysis predictive medicine test for hereditary breast and ovarian cancer; COLARIS medicine test for hereditary colorectal and uterine cancer; COLARIS AP predictive medicine test for hereditary colorectal cancer; and MELARIS medicine test for hereditary melanoma. It also provides OnDose, a personalized medicine test that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients; PANEXIA, a predictive medicine test for pancreatic cancer; PREZEON, a personalized and prognostic medicine test for cancer; Prolaris, a prognostic medicine test for prostate cancer; and TheraGuide 5-FU, a personalized medicine test for drug toxicity. In addition, the company, through its subsidiary, Myriad RBM, Inc., offers biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical research industries that include multi-analyte profile testing services; multiplexed immunoassay kits; and TruCulture, a self-contained whole blood culture that allows pharmaceutical and biotechnology companies to identify drug toxicity prior to human trials. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.
=================
=================

wsjboy

SGEN, heal,seattle genetics,biotchnlgy,cap 5724.95,sh 120.41  SGEN   yahoo  finviz  google  fool  
alpha 90.90,beta 1.13,a_vol 992, er 131104,insi 4.8 2.37,inst 0.0 -3.92,
=================
Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for cancer. Its product candidate, ADCETRIS, has accelerated approval form the U.S. Food and Drug Administration for the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens; and for the treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen. The companyÂ’s ADCETRIS is in Phase III trial for patients with Hodgkin lymphoma at high risk of relapse following ASCT; Phase II retreatment trial for patients with Hodgkin lymphoma or sALCL; Phase II trial for patients with relapsed or refractory CD30-positive non-Hodgkin lymphomas; Phase II CD30-screening and treatment trial for patients with CD30-positive non-lymphoma malignancies; Phase I safety trial in combination with Adriamycin, vinblastine, bleomycin, and dacarbazine, or in combination with AVD for front-line treatment of patients with Hodgkin lymphoma; and Phase I safety trial for the treatment of patients with mature T-cell lymphomas, including sALCL. Its product pipeline also comprises SGN-75, which completed Phase I trial for relapsed or refractory non-Hodgkin lymphoma and renal cell carcinoma; ASG-5ME that is in Phase I trial for treating metastatic pancreatic cancer and castration-resistant prostate cancer; ASG-22ME, which is in Phase I trial for treatment of Nectin-4 -positive solid tumors; and SGN-CD19A for CD19-positive hematologic malignancies. The company has a strategic collaboration with Oxford BioTherapeutics Ltd. to jointly discover antibody-drug conjugates (ADC) for the treatment of cancer. Seattle Genetics, Inc. was founded in 1997 and is headquartered in Bothell, Washington.
=================
=================

wsjboy

occu

wsjboy

POM, util,pepco holdings,electrc utlts, in sp500_set   POM   yahoo  finviz  google  fool  
alpha -4.30,beta 0.43,a_vol 2161, div 5.62 130906,er 131104,debt 1.25,insi 0.3 15.81,inst 61.8 6.28,
=================
Pepco Holdings, Inc., through its subsidiaries, engages in the transmission, distribution, and supply of electricity. The company also distributes and supplies natural gas. It distributes electricity to approximately 1.8 million customers in the mid-Atlantic region and delivers natural gas to approximately 125,000 customers in Delaware. In addition, the company provides energy savings performance contracting services principally to federal, state, and local government customers; and designs, constructs, and operates combined heat and power, and central energy plants. Further, it offers high voltage electric construction and maintenance services, low voltage electric construction and maintenance services, and streetlight construction and asset management services to utilities, municipalities, and other customers in the Washington, District of Columbia area. Additionally, Pepco Holdings, Inc. holds investments in eight cross-border energy lease investments. The company was founded in 1896 and is headquartered in Washington, the District of Columbia.
=================
=================

wsjboy

THRM, csmg,genthermorporated,auto parts  THRM   yahoo  finviz  google  fool  
pe 32.07,peg 1.43,alpha 39.90,beta 1.76,a_vol 301, er 131028,insi 2.3 -1.7,inst 81.7 -1.51,
=================
Gentherm Incorporated develops and markets thermal management technologies for a range of heating and cooling, and temperature control applications worldwide. Its automotive products include actively heated and cooled seat systems and cup holders, heated and ventilated seat systems, thermal storage bins, heated seat and steering wheel systems, cable systems, and other electronic devices. The company offers its products for automobile and truck original equipment manufacturers, Tier 1 suppliers, and other industries; and customer groups related to seat heating equipment for the automotive aftermarket, ski lifts, and sports stadiums. In addition, it is developing materials for thermoelectric and systems of waste heat recovery and electrical power generation for the automotive market that also have applications for consumer products, as well as industrial and technology markets. The company was formerly known as Amerigon Inc. and changed its name to Gentherm Incorporated in September 2012. Gentherm Incorporated was founded in 1968 and is headquartered in Northville, Michigan.
=================
=================

wsjboy

EIX, util,edison intl,electrc utlts, in sp500_set   EIX   yahoo  finviz  google  fool  
pe 11.54,peg 13.91,alpha 2.10,beta 0.58,a_vol 2435, div 2.87 130626,debt 1.12,insi 0.17 -4.48,inst 80.2 -0.77,
=================
Edison International, through its subsidiaries, generates and distributes electric power. It also invests in transportation infrastructure and energy assets, including renewable energy in the Netherlands, Australia, Switzerland, and the United Kingdom. In addition, the company offers capital and financial services. Edison International was formerly known as SCEcorp and changed its name to Edison International in February 1996. The company was founded in 1886 and is based in Rosemead, California with power generation facilities in the United Kingdom, Australia, Indonesia, Italy, Turkey, the Philippines, Thailand, Illinois, and Pennsylvania.
=================
=================

wsjboy

BIOD, heal,biodel,drug manfctrrs-othr  BIOD   yahoo  finviz  google  fool  
alpha 50.20,beta 0.00,a_vol 558, insi 2.63 -3.17,inst 61.5 14.47,
=================
Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. The company is involved in developing proprietary formulations of injectable recombinant human insulin for the treatment of patients with type 1 and type 2 diabetes. It also develops liquid glucagon formulations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia, or very low concentrations of blood glucose. Biodel Inc. was founded in 2003 and is headquartered in Danbury, Connecticut.
=================
=================

wsjboy

SAPE, tech,sapient,businss softwr&servcs  SAPE   yahoo  finviz  google  fool  
pe 30.3,peg 1.73,alpha 57.90,beta 1.33,a_vol 850, er 131104,insi 11.8 2.1,inst 76.1 2.75,
=================
Sapient Corporation provides various services that enable clients to leverage marketing and technology to transform their businesses in the United States and internationally. It operates in three segments: SapientNitro, Sapient Global Markets, and Sapient Government Services. The SapientNitro segment offers Web and interactive development, traditional advertising, media planning and buying, strategic planning and marketing analytics, and multi-channel commerce strategy and solutions. This segment also provides integrated marketing and creative services, such as visual concept, design, and implementation through multiple media; brand building and direct response programs, audience segmentation, and profiling strategies; customer loyalty strategies; customer relationship strategy and implementation; customer lead generation and management; and integrated advertising campaigns. The Sapient Global Markets segment offers services in the areas of buy-side investment process; commodities trading and risk management; derivatives platforms; clearing and collateral; data management; Java; .Net; operational risk; pipeline and shipping; portfolio accounting; trade documentation; trade repository reporting; valuation and risk analytics; and visualization, as well as advisory, program management, analytics, technology, and operations services to capital and commodity markets. The Sapient Government Services segment offers digital marketing strategy and execution, program management, solution delivery, strategy, and communications and outreach services, as well as provides consulting, technology, and marketing services. The company serves financial services, retail, technology and communications, consumer packaged goods, travel and leisure, automotive, energy services, government, health, and education sectors. Sapient Corporation was founded in 1990 and is headquartered in Boston, Massachusetts.
=================
Sapient公司提供各种服务，使客户利用市场营销和技术来改造自己的业务在美国和国际。它工作在三个部分：SapientNitro的，Sapient公司的全球市场，政府和Sapient服务。 SapientNitro的分部提供Web和互动发展，传统的广告，媒体策划和购买，战略规划和市场分析，多渠道商务战略和解决方案。该分部还提供整合营销和创意服务，如视觉概念，设计和实施，通过多种媒体品牌建设和直接响应方案，受众细分，分析策略，客户忠诚度的战略，客户关系战略和实施;客户领先一代和管理，以及综合性的广告活动。 Sapient公司的全球市场分部提供的服务购买方的投资过程中的地区;商品交易和风险管理，衍生产品平台，结算及抵押品;数据管理; JAVA;净经营风险，管道和航运投资组合会计，贸易文件;交易资料储存库报告，估值和风险分析和可视化，以及咨询，项目管理，分析，技术和运营服务的资本和商品市场。 Sapient公司的政府服务部门提供的数字营销策略和执行，项目管理，交付解决方案，策略，以及通信和外展服务，以及提供咨询，技术和营销服务。该公司提供金融服务，零售，技术和通讯，消费品，旅游，休闲，汽车，能源服务，政府，医疗，和教育部门。 Sapient公司始建于1990年，总部设在美国马萨诸塞州的波士顿
=================

wsjboy

CTAS, svcs,cintas,businss servcs, in dvinc_set sp500_set   CTAS   yahoo  finviz  google  fool  
pe 19.27,peg 1.93,alpha 20.30,beta 0.87,a_vol 457, div 1.31 121107,er 130916,insi 1.1 0.45,inst 74.3 -0.47,
=================
Cintas Corporation provides corporate identity uniforms and related business services for approximately 1 million businesses primarily in North America, Latin America, Europe, and Asia. The company operates in four segments: Rental Uniforms and Ancillary Products; Uniform Direct Sales; First Aid, Safety and Fire Protection Services; and Document Management Services. The Rental Uniforms and Ancillary Products segment rents and services uniforms and other garments, including flame resistant clothing, mats, mops and shop towels, and other ancillary items; and provides restroom cleaning services and supplies, and carpet and tile cleaning services. The Uniform Direct Sales segment is involved in the direct sale of uniforms and related items. The First Aid, Safety, and Fire Protection Services segment offers first aid, safety, and fire protection products and services. The Document Management Services segment provides document destruction, document imaging, and document retention services. The company offers its products and services through its distribution network and local delivery routes, or local representatives to small service and manufacturing companies, as well as corporations. Cintas Corporation was founded in 1968 and is headquartered in Cincinnati, Ohio.
=================
=================

wsjboy

SYMC, tech,symantec,securty softwr&servcs, in sp500_set   SYMC   yahoo  finviz  google  fool  
pe 24.75,peg 2.72,alpha 47.40,beta 0.97,a_vol 8144, div 2.29 130822*,er 131023,insi 0.2 20.69,inst 93.3 0.59,
=================
Symantec Corporation and its subsidiaries provide security, backup, and availability solutions worldwide. Its products and services protect people and information in any digital environment from mobile devices, enterprise data centers, and cloud-based systems. The company operates in Consumer, Security and Compliance, Storage and Server Management, and Services segments. The Consumer segment provides Internet security for PCs, tablets, and mobile devices; services, such as online backup, online family protection, and remote help to individual users and home offices; and various free tools and trial products to consumers. The Security and Compliance segment offers security solutions for endpoint security and management, compliance, mail security, data loss prevention, encryption, managed security services, and authentication services. Its solutions allow its customers to secure, provision, and remotely manage their laptops, PCs, mobile devices, and servers. The Storage and Server Management segment provides storage and server management, backup, archiving, eDiscovery, and data protection solutions across heterogeneous storage and server platforms, as well as solutions through its cloud and appliance offerings. The Services segment offers consulting, business critical services, and education and dedicated support services to help customers address information security, availability, storage, and compliance needs. The company markets and sells its products and related services through its direct sales force and eCommerce platform, as well as through distributors, direct marketers, Internet-based resellers, system builders, Internet service providers, wireless carriers, original equipment manufacturers, specialized partners, value-added resellers, large account resellers, managed service providers, system integrators, and in retail locations. Symantec Corporation was founded in 1982 and is headquartered in Mountain View, California.
=================
=================

wsjboy

TSS, tech,total system services,businss softwr&servcs, in sp500_set   TSS   yahoo  finviz  google  fool  
pe 22.46,peg 1.59,alpha 24.70,beta 0.92,a_vol 1438, div 1.43 130618,er 131021,insi 1.3 -5.95,inst 71.6 1.57,
=================
Total System Services, Inc. provides payment processing and other services to card-issuing and merchant acquiring institutions in the United States and internationally. It operates through three segments: North America Services, International Services, and Merchant Services. The company offers issuer account solutions, including processing the card application, initiating service for the cardholder, processing each card transaction for the issuing retailer or financial institution and accumulating the accountÂ’s transactions; fraud management services for monitoring the unauthorized use of accounts; fraud detection systems for identifying fraudulent transactions; and other services, such as customized communications to cardholders, information verification associated with granting credit, debt collection, and customer service. It also provides processing services, acquiring solutions, related systems, and integrated support services, which include processing various payment forms comprising credit, debit, prepaid, electronic benefit transfer, and electronic check; authorization and capture of transactions; clearing and settlement of transactions; information reporting services related to transactions; merchant billing services; and point-of-sale equipment sales and service. In addition, the company offers transaction processing, merchant support and underwriting, and business and value-added services, as well as prepaid cards for businesses. Total System Services, Inc. provides its services through online accounting and electronic payment processing systems. The company was founded in 1982 and is based in Columbus, Georgia.
=================
=================

wsjboy

FISV, svcs,fiserv,businss servcs, in sp500_set   FISV   yahoo  finviz  google  fool  
pe 23.6,peg 1.98,alpha 41.60,beta 1.00,a_vol 608, er 131028,debt 1.14,insi 1.8 0.93,inst 90.1 -3.13,
=================
Fiserv, Inc., together with its subsidiaries, provides financial services technology worldwide. The companyÂ’s Payments and Industry Products segment offers electronic bill payment and presentment, card-based transaction processing and network services, ACH transaction processing, account-to-account transfer products, and person-to-person payments; Internet and mobile banking systems; and related services, including document and payment card production and distribution, check processing and imaging, source capture systems, and lending and risk management products and services. This segment also provides investment account processing services for separately managed accounts, card and print personalization services, and fraud and risk management products and services. Its Financial Institution Services segment offers account processing services, item processing and source capture services, loan origination and servicing products, cash management and consulting services, and other products and services that support various types of financial transactions to banks, thrifts, and credit unions. The company also provides consumer and business payments solutions, such as account-to-account transfer, account opening and funding, data aggregation, small business invoicing and payments, and person-to-person payments services. It serves banks, thrifts, credit unions, investment management firms, leasing and finance companies, retailers, merchants, and government agencies. Fiserv, Inc. was founded in 1984 and is headquartered in Brookfield, Wisconsin.
=================
=================

wsjboy

LIFE, heal,life technologies,medicl labrtrs&resrch, in sp500_set   LIFE   yahoo  finviz  google  fool  
pe 30.88,peg 3.11,alpha 57.40,beta 0.94,a_vol 2038, insi 0.2 234.88,inst 81.3 -11.22,
=================
Life Technologies Corporation operates as a life sciences company. The companyÂ’s Research Consumables business group offers molecular and cell biology reagents, endpoint PCR, and other benchtop instruments and consumables, such as RNAi, DNA synthesis, sample prep, transfection, cloning and protein expression profiling and protein analysis, cell culture media used in research, stem cells and related tools, cellular imaging products, antibodies, and cell therapy related products. Its Genetic Analysis business group provides capillary electrophoresis (CE) instruments used for research applications and various CE consumables; real-time and digital qPCR instruments used in research applications; qPCR consumables and genomic assays; and sequencing systems and reagents for the SOLiD and Ion Torrent systems. The companyÂ’s Applied Sciences business group offers bioproduction, forensics, and animal health and food safety reagent kits; CE; and qPCR instruments that are used in applied markets applications; and medical sciences products consisting of molecular diagnostics products and services, including laboratory-developed tests and transplant diagnostics. Life Technologies Corporation also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions worldwide. The company was founded in 1987 and is headquartered in Carlsbad, California.
=================
=================